Dr Chanel Allen-Megahey

Dr Chanel Allen-Megahey has a strong background in regulatory affairs and quality management, spanning a period of over 20 years. Dr Chanel has held various senior positions in different companies and industries.

In 2000, they served as the Head of RA/QA at HeartSine Technologies for four years before moving on to work as a Quality Consultant at TriVirix in 2004.

From 2006 to 2010, Dr Allen-Megahey worked as the Group Compliance Officer at Survitec Group.

In 2011, they founded their own company called DRCAM SOLUTIONS LTD, where they served as a Business Owner. Dr Chanel also worked as a Quality Consultant at Thompson Aero Seating Limited during this time until 2013 when they became the V.P Quality.

Dr Chanel continued to work in the regulatory affairs field, serving as an Aerospace Quality Consultant at DRCAM SOLUTIONS LTD in 2013.

From 2014 to 2015, Dr Allen-Megahey served as the Group Quality Manager at Camden Group Limited.

In 2015, they joined TG Eakin as a Regulatory Affairs Manager.

In 2019, they became the Global QARA Director at Quanta Dialysis Technologies, where they were responsible for leading the global quality and regulatory affairs functions.

In 2020, Dr Allen-Megahey joined CMR Surgical as the Global Head of Regulatory Affairs.

Currently, they are serving as the Director of Regulatory Affairs Quality H&S at Advanced Oncotherapy plc, a position they started in 2023.

Dr Chanel Allen-Megahey has a Bachelor of Science (Bsc Hons) degree in Biological Sciences from Queen's University Belfast. Dr Chanel also holds a PhD in Applied Plant Science from the same institution. In addition, they have a BTec Higher National Diploma (HND) in Applied Biology from Ulster University. The specific start and end years for each of these educational experiences are not provided.